| • |
A single, minimally invasive treatment. |
| • |
Typically an outpatient procedure with fewer complications than traditional surgery. |
| • |
Only stereotactic radiosurgery device that is FDA approved to treat brain metastases. |
| • |
Can treat single and multiple brain metastases from a variety of primary cancers such as lung, breast, colon, kidney, prostate, bladder and melanoma. |
| • |
Patients return to pretreatment activities within days, requiring little or no rehabilitative services. |
| • |
Reimbursed by most insurance payors, including Medicare. |
| • |
| Over 2,000 peer-review clinical articles support its use for: |
| » |
Malignant and benign brain tumors |
| » |
Arteriovenous malformations (AVMs) |
| » |
Trigeminal neuralgia |
|
